1.A Case of Cecal Volvulus Diagnosed with Abdominal Computed Tomography.
Dae Jhun HWANG ; Tae Hwa KIM ; Ji Woong CHO ; Hae Wan LEE ; Byoung Yoon RYU ; Hong Ki KIM ; Bong Soo KIM
Journal of the Korean Society of Coloproctology 2003;19(1):48-51
Cecal volvulus is a rare disease of the colon, which occurs in less than 2% of adult intestinal obstruction cases. Precipitating factors can be identified in some patients, including adhesions, a recent abdominal operation, congenital bands, pregnancy, violent exercise, malrotation, obstructing lesions of the left colon and colonoscopy, etc. A right colectomy is a definitive treatment for the best long term control of symptoms, and is the treatment of choice when gangrenous changes are present in the bowel. However, in the presence of viable bowel, the preferred treatment is a controversial matter, with options including; detorsion, cecopexy and cecostomy, etc. We experienced a case of cecal vovulus, which had been treated for COPD at ICU. A diagnosis was made with abdominal computed tomography, and a right hemicolectomy was performed.
Adult
;
Cecostomy
;
Colectomy
;
Colon
;
Colonoscopy
;
Diagnosis
;
Humans
;
Intestinal Obstruction
;
Intestinal Volvulus*
;
Precipitating Factors
;
Pregnancy
;
Pulmonary Disease, Chronic Obstructive
;
Rare Diseases
2.Surgical Treatment of Graves' Disease.
Dae Jhun HWANG ; Sang Dal LEE ; Seok Jin NAM ; Youn Ryun OH ; Jae Hoon CHUNG ; Jung Hyun YANG
Journal of the Korean Surgical Society 2000;58(4):494-501
PURPOSE: Graves' disease can be treated with antithyroid medication, radioiodine, or a thyroidectomy. Antithyroid medication is less likely to achieve a permanent remission than radioiodine or thyroidectomy. Radioiodine is preferred in the United States and antithyroid medication is used more often in Europe. However a thyroidectomy is less preferred as a primary therapy and is used only in the cases of recurrence or no response to medication. METHODS: We studied 152 patients with Graves' disease who had been treated at Samsung Medical Center. Fifty seven patients of them were surgically managed after antithyroid medication, and the rest of them were managed medically. Patient's age, sex, symptoms, thyroid fuction, autoantibody, treatment method and recurrence were retrospectively analyzed. RESULTS: Women had Graves' disease more frequently than men a thyroidectomy was performed more often in women and relatively young patients. The symptoms of Graves' disease were neck mass, palpitation, eye symptoms, weight loss and etc. The response to treatment was much higher in the thyroidectomy group than in the medically treated group. And more patients in surgically treatmented group had their thyroid function normalized. A subtotal thyroidectomy was performed in all patient and a mean of 7.4 g of thyroid tissue was remained. Hypothyroidism was noted in 7 patients (12.3%), permanent hypocalcemia in 1 (1.8%), vocal cord paralysis in 1 (1.8%) and transient hoarseness, transient hypocalcemia in the others. Recurrences were noted in 4 patients. There was no correlation between recurrence and remnant thyroid mass. However, preoperative TBII (thyrotropine binding inhibiting immunoglobulin) values were higher in recurrence group and immediate and late postoperative values were also higher than in the recovered group. CONCLUSION: A thyroidectomy is the treatment of choice in Graves' disease. However, further investigation will be needed to predict thyroid the function after a thyroidectomy for Graves' disease
Europe
;
Female
;
Graves Disease*
;
Hoarseness
;
Humans
;
Hypocalcemia
;
Hypothyroidism
;
Male
;
Neck
;
Recurrence
;
Retrospective Studies
;
Thyroid Gland
;
Thyroidectomy
;
United States
;
Vocal Cord Paralysis
;
Weight Loss
3.Surgical Treatment of Graves' Disease.
Dae Jhun HWANG ; Sang Dal LEE ; Seok Jin NAM ; Youn Ryun OH ; Jae Hoon CHUNG ; Jung Hyun YANG
Journal of the Korean Surgical Society 2000;58(4):494-501
PURPOSE: Graves' disease can be treated with antithyroid medication, radioiodine, or a thyroidectomy. Antithyroid medication is less likely to achieve a permanent remission than radioiodine or thyroidectomy. Radioiodine is preferred in the United States and antithyroid medication is used more often in Europe. However a thyroidectomy is less preferred as a primary therapy and is used only in the cases of recurrence or no response to medication. METHODS: We studied 152 patients with Graves' disease who had been treated at Samsung Medical Center. Fifty seven patients of them were surgically managed after antithyroid medication, and the rest of them were managed medically. Patient's age, sex, symptoms, thyroid fuction, autoantibody, treatment method and recurrence were retrospectively analyzed. RESULTS: Women had Graves' disease more frequently than men a thyroidectomy was performed more often in women and relatively young patients. The symptoms of Graves' disease were neck mass, palpitation, eye symptoms, weight loss and etc. The response to treatment was much higher in the thyroidectomy group than in the medically treated group. And more patients in surgically treatmented group had their thyroid function normalized. A subtotal thyroidectomy was performed in all patient and a mean of 7.4 g of thyroid tissue was remained. Hypothyroidism was noted in 7 patients (12.3%), permanent hypocalcemia in 1 (1.8%), vocal cord paralysis in 1 (1.8%) and transient hoarseness, transient hypocalcemia in the others. Recurrences were noted in 4 patients. There was no correlation between recurrence and remnant thyroid mass. However, preoperative TBII (thyrotropine binding inhibiting immunoglobulin) values were higher in recurrence group and immediate and late postoperative values were also higher than in the recovered group. CONCLUSION: A thyroidectomy is the treatment of choice in Graves' disease. However, further investigation will be needed to predict thyroid the function after a thyroidectomy for Graves' disease
Europe
;
Female
;
Graves Disease*
;
Hoarseness
;
Humans
;
Hypocalcemia
;
Hypothyroidism
;
Male
;
Neck
;
Recurrence
;
Retrospective Studies
;
Thyroid Gland
;
Thyroidectomy
;
United States
;
Vocal Cord Paralysis
;
Weight Loss
4.Osteogenic Sarcoma of the Breast.
Byoung Yoon RYU ; Tae Hwa KIM ; Hae Sung KIM ; Dae Jhun HWANG ; Ji Woong CHO ; Hae Wan LEE ; Hong Ki KIM ; Hong SEOK ; Young Hee CHOI
Journal of the Korean Surgical Society 2001;61(4):441-444
Osteogenic sarcoma is a rare breast tumor. The first report of a malignant mammary neoplasm composed of bone and cartilage was that of Bonet in 1700. Meanwhile in Korea, Kim et al reported one case of osteosarcoma of the breast in 1999. A 44 year old woman visited our hospital because of a mass on her right breast. The mass was fixed on the skin and 5 5 cm in size. Following a frozen biopsy result of malignancy. A modified radical mastectomy was performed. The tumor was confirmed histologically and immunohistochemically as an osteogenic sarcoma. This study presents one case of an osteogenic sarcoma of the breast, and the report of this rare breast tumor is accompanied by a review of the literature.
Adult
;
Animals
;
Biopsy
;
Breast Neoplasms
;
Breast*
;
Cartilage
;
Female
;
Humans
;
Korea
;
Mammary Neoplasms, Animal
;
Mastectomy, Modified Radical
;
Osteosarcoma*
;
Skin
5.The Progression of SARS Coronavirus 2 (SARS-CoV2): Mutation in the Receptor Binding Domain of Spike Gene
Sinae KIM ; Jong Ho LEE ; Siyoung LEE ; Saerok SHIM ; Tam T. NGUYEN ; Jihyeong HWANG ; Heijun KIM ; Yeo-Ok CHOI ; Jaewoo HONG ; Suyoung BAE ; Hyunjhung JHUN ; Hokee YUM ; Youngmin LEE ; Edward D. CHAN ; Liping YU ; Tania AZAM ; Yong-Dae KIM ; Su Cheong YEOM ; Kwang Ha YOO ; Lin-Woo KANG ; Kyeong-Cheol SHIN ; Soohyun KIM
Immune Network 2020;20(5):e41-
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is a positive-sense singlestranded RNA (+ssRNA) that causes coronavirus disease 2019 (COVID-19). The viral genome encodes twelve genes for viral replication and infection. The third open reading frame is the spike (S) gene that encodes for the spike glycoprotein interacting with specific cell surface receptor – angiotensin converting enzyme 2 (ACE2) – on the host cell membrane. Most recent studies identified a single point mutation in S gene. A single point mutation in S gene leading to an amino acid substitution at codon 614 from an aspartic acid 614 into glycine (D614G) resulted in greater infectivity compared to the wild type SARS-CoV2. We were interested in investigating the mutation region of S gene of SARS-CoV2 from Korean COVID-19 patients. New mutation sites were found in the critical receptor binding domain (RBD) of S gene, which is adjacent to the aforementioned D614G mutation residue. This specific sequence data demonstrated the active progression of SARS-CoV2 by mutations in the RBD of S gene.The sequence information of new mutations is critical to the development of recombinant SARS-CoV2 spike antigens, which may be required to improve and advance the strategy against a wide range of possible SARS-CoV2 mutations.